Decapeptyl SR 11.25mg powder and solvent for suspension for injection 1 vial

In women, endometriosis and uterine fibroids are treated with triptorelin. Endometriosis is a condition where tissue resembling the womb or uterus lining (endometrium) grows in other sites in the body. The growth of this tissue is stimulated by oestrogen, so decreasing oestrogen levels with triptorelin will stop the growth of this tissue, thereby relieving symptoms.

In men, the growth of some prostate cancers is stimulated by testosterone. Reducing the body's levels of testosterone therefore deprives the tumour of testosterone and causes it to shrink.

Triptorelin (I.N.N.) 15 mg, as triptorelin acetate.

The vial contains an overage to ensure that a dose of 11.25 mg is administered to the patient.

Keep your medicine out of the reach and sight of children.

Do not store above 25°C and keep the container in the outer carton, to protect from light.

Do not use after the expiry date shown on the box.

The following rare reactions have been reported: allergic reactions, headache, weight gain, increased blood pressure, blurred or abnormal vision, gastrointestinal disorders including abdominal pain and vomiting, nose bleeding, feeling unwell, muscle pain, mood disorders and nervousness.

If any side effect is troublesome, or causes you concern, you should tell your doctor. If you notice any side effects not mentioned in this leaflet, please inform your doctor or pharmacist.